Back to Journals » Drug Design, Development and Therapy » Volume 16
Retraction
A Novel Glycyrrhetinic Acid-Modified Oxaliplatin Liposome for Liver-Targeting and in vitro/vivo Evaluation [Retraction]
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
2,406 | Dovepress* | 2,307+ | 50 | 2,357 | |
PubMed Central* | 99 | 46 | 145 | ||
Totals | 2,406 | 96 | 2,502 | ||
*Since 18 November 2022 |
View citations on PubMed Central and Google Scholar